Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

Publisher Name :
Date: 18-Aug-2023
No. of pages: 179
Inquire Before Buying

“Increasing R&D investments and growing number of CROs are driving the global growth of the clinical trial imaging market”

The global clinical trial imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 7.8% during the forecast period. The market's expansion is propelled by factors including the expansion of the pharmaceutical and biotechnology sectors, escalated research and development investments, and the proliferation of Contract Research Organizations (CROs). On the other hand, the high implementation cost of the imaging system and high cost of clinical trials are the major factors hindering the growth of this market during the forecast period.

The service segment accounted for the highest growth rate in the clinical trial imaging market, by service & software, during the forecast period”

The clinical trial imaging market is segmented into services and software based on product. In 2022, the service segment accounted for the highest growth rate in the clinical trial imaging market. Based on type, the services segment is further classified into operational imaging services, reader analysis services, system & technical support services, and trial design consulting services. The growth of this segment is primarily attributed to the rising R&D spending, expanding clinical trials, and the demand for new disease treatment and diagnostics.

“Medical device manufacturers segment accounted for the highest CAGR”

Based on end user, the clinical trial imaging market is segmented into pharmaceutical companies, biotechnology companies, medical devices manufacturers, contract research organizations, academic and government research institutes, and other end users. In 2022, the medical device manufacturers segment accounted for the highest growth rate. This can be attributed to the increasing R&D expenditure and R&D activities by medical device manufacturers and the expanding medical devices market are the primary growth drivers of the medical device manufacturers segment.

Asia Pacific: The fastest-growing region clinical trial imaging market”

The global clinical trial imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. The surge in research and development investments and the growing inclination towards outsourcing pharmaceutical research to emerging Asian nations are the pivotal catalysts propelling the market's expansion.

The primary interviews conducted for this report can be categorized as follows:


  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%

  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%

  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%


Prominent companies are ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US), Median Technologies (France) and Invicro. LLC. (US).

Research Coverage:

This research report categorizes the clinical trial imaging market by service & software, modality, therapeutic area, end user and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the clinical trial imaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the clinical trial imaging market. Competitive analysis of upcoming startups in the clinical trial imaging market ecosystem is covered in this report.   

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial imaging market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:


  • Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the clinical trial imaging market.

  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the clinical trial imaging market.

  • Market Development: Comprehensive information about lucrative markets – the report analyses the clinical trial imaging market across varied regions.

  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical trial imaging market.

  • Competitive Assessment: In-depth assessment of market ranking, growth strategies and service offerings of leading players like ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), and Medpace Holdings, Inc. (US), among others in the clinical clinical trial imaging market strategies.  

Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

Table Of Contents

1 Introduction 25
1.1 Study Objectives 25
1.2 Market Definition 25
1.2.1 Inclusions And Exclusions 25
1.2.2 Markets Covered 26
Figure 1 Clinical Trial Imaging Market Segmentation 26
1.2.3 Geographic Scope 27
1.2.4 Years Considered 27
1.2.5 Currency Considered 28
1.3 Limitations 28
1.4 Stakeholders 28
1.5 Summary Of Changes 29
1.5.1 Recession Impact 29

2 Research Methodology 30
2.1 Research Data 30
2.2 Research Approach 30
Figure 2 Clinical Trial Imaging Market: Research Design 30
2.2.1 Secondary Data 30
2.2.1.1 Key Data From Secondary Sources 31
2.2.2 Primary Data 32
Figure 3 Breakdown Of Interviews: Supply And Demand Side 32
2.2.2.1 Key Data From Primary Sources 33
2.2.2.2 Key Industry Insights 34
2.2.2.3 Breakdown Of Primary Interviews 34
Figure 4 Breakdown Of Primary Interviews: Supply And Demand-Side Participants 34
Figure 5 Breakdown Of Primary Interviews: By Company Type, Designation, And Region 35
2.3 Market Size Estimation 35
2.3.1 Bottom-Up Approach 36
2.3.1.1 Approach 1: Company Revenue Estimation Approach 36
Figure 6 Bottom-Up Approach: Company Revenue Estimation Approach 36
2.3.1.2 Approach 2: Presentations Of Companies And Primary Interviews 36
2.3.1.3 Growth Forecast 37
2.3.1.4 Cagr Projections 37
Figure 7 Cagr Projections: Supply-Side Analysis 37
2.3.2 Top-Down Approach 38
Figure 8 Clinical Trial Imaging Market: Top-Down Approach 38
2.4 Market Breakdown & Data Triangulation 39
Figure 9 Data Triangulation Methodology 39
2.5 Study Assumptions 40
2.6 Risk Assessment 40
2.7 Limitations 41
2.8 Clinical Trial Imaging Market: Recession Impact 41

3 Executive Summary 43
Figure 10 Clinical Trial Imaging Market, By Service & Software, 2023 Vs. 2028 (Usd Million) 43
Figure 11 Clinical Trial Imaging Market, By Modality, 2023 Vs. 2028 (Usd Million) 44
Figure 12 Clinical Trial Imaging Market, By Therapeutic Area, 2023 Vs. 2028 (Usd Million) 45
Figure 13 Clinical Trial Imaging Market, By End User, 2023 Vs. 2028 (Usd Million) 46
Figure 14 Clinical Trial Imaging Market, By Region, 2023 Vs. 2028 (Usd Million) 47

4 Premium Insights 48
4.1 Clinical Trial Imaging Market Overview 48
Figure 15 Rising R&D Spending To Drive Market Growth 48
4.2 Clinical Trial Imaging Market Share, By Service & Software, 2022 Vs. 2028 48
Figure 16 Services To Hold Largest Market Share Till 2028 48
4.3 Clinical Trial Imaging Market Share, By Modality, 2023 Vs. 2028 49
Figure 17 Computed Tomography To Command Largest Share Over Forecast Period 49
4.4 Clinical Trial Imaging Market Share, By Therapeutic Area, 2023 Vs. 2028 49
Figure 18 Oncology To Dominate Market, By Therapeutic Area, Till 2028 49
4.5 Clinical Trial Imaging Market Share, By End User, 2023 Vs. 2028 50
Figure 19 Pharmaceutical Companies To Retain Market Leadership Over Forecast Period 50
4.6 Clinical Trial Imaging Market: Geographic Growth Opportunities 50
Figure 20 Asia Pacific To Register Highest Growth Rate Till 2028 50

5 Market Overview 51
5.1 Introduction 51
5.2 Market Dynamics 51
Figure 21 Clinical Trial Imaging Market: Drivers, Restraints, Opportunities, And Challenges 51
5.2.1 Drivers 52
5.2.1.1 Increasing R&D Spending 52
5.2.1.2 Growth Of Pharmaceutical And Biotechnology Industries 52
5.2.1.3 Increasing Number Of Cros 52
5.2.2 Restraints 53
5.2.2.1 High Implementation Cost Of Imaging Systems 53
5.2.3 Opportunities 53
5.2.3.1 Growth Opportunities In Emerging Economies 53
5.2.3.2 Development Of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, And Radiopharmaceuticals 53
5.2.4 Challenges 54
5.2.4.1 High Cost Of Clinical Trials 54
5.3 Pricing Analysis 54
Table 1 Prices Of Clinical Trial Imaging Products (2022) 54
5.4 Patent Analysis 55
5.5 Trade Analysis 55
5.5.1 Trade Analysis For X-Ray Apparatuses 55
Table 2 Import Data For X-Ray Apparatuses, By Country, 2018–2022 (Usd Million) 55
Table 3 Export Data For X-Ray Apparatuses, By Country, 2018–2022 (Usd Million) 56
5.5.2 Trade Analysis For Ct Apparatuses 56
Table 4 Import Data For Ct Apparatuses, By Country, 2018–2022 (Usd Million) 56
Table 5 Export Data For Ct Apparatuses, By Country, 2018–2022 (Usd Million) 57
5.6 Value Chain Analysis 57
Figure 22 Clinical Trial Imaging Market: Value Chain Analysis 57
5.7 Supply Chain Analysis 58
Figure 23 Clinical Trial Imaging Market: Supply Chain Analysis 59
5.8 Ecosystem Analysis 59
Figure 24 Clinical Trial Imaging Market: Ecosystem Analysis 59
Table 6 Company Role In Ecosystem 60
5.9 Porter’s Five Forces Analysis 61
Table 7 Clinical Trial Imaging Market: Porter’s Five Forces Analysis 61
5.9.1 Threat Of New Entrants 61
5.9.2 Threat Of Substitutes 61
5.9.3 Bargaining Power Of Buyers 61
5.9.4 Bargaining Power Of Suppliers 61
5.9.5 Degree Of Competition 61
5.10 Pestle Analysis 62
5.11 Regulatory Landscape 62
5.11.1 North America 62
5.11.1.1 Us 62
5.11.1.2 Canada 63
5.11.2 Europe 63
5.11.3 Asia Pacific 63
5.11.3.1 Japan 63
5.11.3.2 India 63
5.11.3.3 China 64
5.11.4 Latin America 64
5.11.4.1 Brazil 64
5.11.4.2 Mexico 64
5.11.5 Middle East 65
5.11.6 Africa 65
5.12 Technology Analysis 65
5.13 Clinical Trial Imaging: Disruptive Technologies 66
Figure 25 Revenue Shift In Clinical Trial Imaging Market 66

6 Clinical Trial Imaging Market, By Service & Software 67
6.1 Introduction 68
Table 8 Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 68
6.2 Services 68
Table 9 Clinical Trial Imaging Services Market, By Type, 2021–2028 (Usd Million) 68
Table 10 Clinical Trial Imaging Services Market, By Region, 2021–2028 (Usd Million) 69
6.2.1 Operational Imaging Services 69
6.2.1.1 Rising Number Of Cros To Drive Market 69
Table 11 Operational Imaging Services Market, By Region, 2021–2028 (Usd Million) 69
6.2.2 Read Analysis Services 70
6.2.2.1 Growing Clinical Trial Activity To Support Growth 70
Table 12 Read Analysis Services Market, By Region, 2021–2028 (Usd Million) 70
6.2.3 System & Technical Support Services 70
6.2.3.1 Need For Continuous Technical Support To Drive Market 70
Table 13 System & Technical Support Services Market, By Region, 2021–2028 (Usd Million) 71
6.2.4 Trial Design & Consulting Services 71
6.2.4.1 Rising R&D Spending And Need For Clinical Trial Support To Boost Outsourcing 71
Table 14 Trial Design & Consulting Services Market, By Region, 2021–2028 (Usd Million) 71
6.3 Software 72
6.3.1 High Efficiency And Cost-Saving Benefits Of Software To Boost Adoption 72
Table 15 Clinical Trial Imaging Software Market, By Region, 2021–2028 (Usd Million) 72

7 Clinical Trial Imaging Market, By Modality 73
7.1 Introduction 74
Table 16 Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 74
7.2 Ct 74
7.2.1 Quick Results And Lack Of Visible Side Effects To Drive Adoption 74
Table 17 Clinical Trial Imaging Market For Ct, By Region, 2021–2028 75
7.3 Mri 75
7.3.1 Increasing Adoption Of Mri In Oncological Trials And Studies To Drive Market 75
Table 18 Clinical Trial Imaging Market For Mri, By Region, 2021–2028 (Usd Million) 76
7.4 Ultrasound 76
7.4.1 High Safety To Ensure Continued Demand 76
Table 19 Clinical Trial Imaging Market For Ultrasound, By Region, 2021–2028 (Usd Million) 77
7.5 Pet 77
7.5.1 Ability To Assess Pharmacokinetic And Pharmacodynamic Events To Boost Adoption 77
Table 20 Clinical Trial Imaging Market For Pet, By Region, 2021–2028 (Usd Million) 78
7.6 X-Ray 78
7.6.1 Wide Usage In Bone, Chest, And Dental Imaging To Drive Market 78
Table 21 Clinical Trial Imaging Market For X-Ray, By Region, 2021–2028 (Usd Million) 79
7.7 Echocardiography 79
7.7.1 Advantages In Defining And Qualifying Populations To Boost Usage 79
Table 22 Clinical Trial Imaging Market For Echocardiography, By Region, 2021–2028 (Usd Million) 79
7.8 Other Modalities 80
Table 23 Clinical Trial Imaging Market For Other Modalities, By Region, 2021–2028 (Usd Million) 80

8 Clinical Trial Imaging Market, By Therapeutic Area 81
8.1 Introduction 82
Table 24 Clinical Trial Imaging Market, By Therapeutic Area, 2021–2028 (Usd Million) 82
8.2 Oncology 82
8.2.1 Increasing Incidence Of Cancer To Drive Market 82
Table 25 Clinical Trial Imaging Market For Oncology, By Region, 2021–2028 (Usd Million) 83
8.3 Infectious Diseases 83
8.3.1 Rising Drug Discovery Activity To Boost Demand For Imaging 83
Table 26 Clinical Trial Imaging Market For Infectious Diseases, By Region, 2021–2028 (Usd Million) 84
8.4 Neurology 84
8.4.1 Growing Investments In Cns Disorder Research To Drive Market 84
Table 27 Clinical Trial Imaging Market For Neurology, By Region, 2021–2028 (Usd Million) 85
8.5 Cvs Disorders 85
8.5.1 High Mortality Rate Of Cvd To Increase Clinical Trial Activity 85
Table 28 Clinical Trial Imaging Market For Cvs Disorders, By Region, 2021–2028 (Usd Million) 86
8.6 Endocrinology 86
8.6.1 Rising Incidence Of Diabetes To Drive Market 86
Table 29 Clinical Trial Imaging Market For Endocrinology, By Region, 2021–2028 (Usd Million) 87
8.7 Immunological Disorders 87
8.7.1 Wide Prevalence Of Allergies, Asthma, And Autoimmune Diseases To Support Demand For Imaging In Trials 87
Table 30 Clinical Trial Imaging Market For Immunological Disorders, By Region, 2021–2028 (Usd Million) 87
8.8 Other Therapeutic Areas 88
Table 31 Clinical Trial Imaging Market For Other Therapeutic Areas, By Region, 2021–2028 (Usd Million) 88

9 Clinical Trial Imaging Market, By End User 89
9.1 Introduction 90
Table 32 Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 90
9.2 Pharmaceutical Companies 90
9.2.1 Pharma Companies To Hold Largest Share Of End-User Market 90
Figure 26 Rising R&D Investments In Pharmaceutical Industry, 2012–2026 (Usd Billion) 91
Table 33 Clinical Trial Imaging Market For Pharmaceutical Companies, By Region, 2021–2028 (Usd Million) 91
9.3 Biotechnology Companies 92
9.3.1 Rising R&D Budgets Of Biotech Companies To Drive Market 92
Table 34 Top Biotechnology Investment Deals, 2020 92
Table 35 Clinical Trial Imaging Market For Biotechnology Companies, By Region, 2021–2028 (Usd Million) 93
9.4 Medical Device Manufacturers 93
9.4.1 Increasing R&D Spending By Medical Devices Manufacturers To Support Growth 93
Table 36 Clinical Trial Imaging Market For Medical Device Manufacturers, By Region, 2021–2028 (Usd Million) 94
9.5 Cros 94
9.5.1 Increasing Trend Of Outsourcing To Drive Market 94
Table 37 Clinical Trial Imaging Market For Cros, By Region, 2021–2028 (Usd Million) 95
9.6 Academic & Government Research Institutes 95
9.6.1 Increasing Research Activity To Drive Market 95
Table 38 Clinical Trial Imaging Market For Academic & Government Research Institutes, By Region, 2021–2028 (Usd Million) 96
9.7 Other End Users 96
Table 39 Clinical Trial Imaging Market For Other End Users, By Region, 2021–2028 (Usd Million) 96

10 Clinical Trial Imaging Market, By Region 97

10.1 Introduction 98
Table 40 Clinical Trial Imaging Market, By Region, 2021–2028 (Usd Million) 98
10.2 North America 98
Figure 27 North America: Clinical Trial Imaging Market Snapshot 99
10.2.1 North America: Recession Impact 99
Table 41 North America: Clinical Trial Imaging Market, By Country, 2021–2028 (Usd Million) 100
Table 42 North America: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 100
Table 43 North America: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 100
Table 44 North America: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 101
10.2.2 Us 101
10.2.2.1 Rising Biopharma Investment To Favor Market Growth 101
Table 45 Us: Product Approvals In Clinical Trial Imaging 101
Table 46 Us: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 102
Table 47 Us: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 102
Table 48 Us: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 103
10.2.3 Canada 103
10.2.3.1 Rising Per Capita Healthcare Spending To Drive Market 103
Table 49 Canada: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 103
Table 50 Canada: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 104
Table 51 Canada: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 104
10.3 Europe 105
10.3.1 Europe: Recession Impact 105
Table 52 Europe: Clinical Trial Imaging Market, By Country, 2021–2028 (Usd Million) 106
Table 53 Europe: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 106
Table 54 Europe: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 107
Table 55 Europe: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 107
10.3.2 Germany 108
10.3.2.1 Germany To Dominate Clinical Trial Imaging Market In Europe 108
Table 56 Germany: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 108
Table 57 Germany: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 108
Table 58 Germany: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 109
10.3.3 Uk 109
10.3.3.1 Favorable Government Initiatives And Growing R&D Spending To Drive Market 109
Table 59 Uk: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 109
Table 60 Uk: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 110
Table 61 Uk: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 110
10.3.4 France 111
10.3.4.1 Presence Of Leading Pharmaceutical Companies To Support Growth 111
Table 62 France: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 111
Table 63 France: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 111
Table 64 France: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 112
10.3.5 Italy 112
10.3.5.1 Increasing Drug Approvals To Ensure Sustained Demand For Clinical Trial Imaging 112
Table 65 Italy: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 112
Table 66 Italy: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 113
Table 67 Italy: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 113
10.3.6 Spain 113
10.3.6.1 Increasing Biologics Production To Support Market Growth 113
Table 68 Spain: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 114
Table 69 Spain: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 114
Table 70 Spain: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 115
10.3.7 Rest Of Europe 115
Table 71 Rest Of Europe: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 115
Table 72 Rest Of Europe: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 116
Table 73 Rest Of Europe: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 116
10.4 Asia Pacific 117
Figure 28 Asia Pacific: Clinical Trial Imaging Market Snapshot 117
10.4.1 Asia Pacific: Recession Impact 118
Table 74 Asia Pacific: Clinical Trial Imaging Market, By Country, 2021–2028 (Usd Million) 118
Table 75 Asia Pacific: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 118
Table 76 Asia Pacific: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 119
Table 77 Asia Pacific: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 119
10.4.2 China 120
10.4.2.1 China To Dominate Apac Market Throughout Forecast Period 120
Table 78 China: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 120
Table 79 China: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 120
Table 80 China: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 121
10.4.3 Japan 121
10.4.3.1 Rising Population And Healthcare Expenditure To Favor Market Growth 121
Table 81 Japan: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 121
Table 82 Japan: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 122
Table 83 Japan: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 122
10.4.4 India 123
10.4.4.1 Rising R&D Investment To Boost Adoption Of Clinical Trial Imaging 123
Table 84 India: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 123
Table 85 India: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 124
Table 86 India: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 124
10.4.5 Rest Of Asia Pacific 125
Table 87 Rest Of Asia Pacific: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 125
Table 88 Rest Of Asia Pacific: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 125
Table 89 Rest Of Asia Pacific: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 126
10.5 Latin America 126
10.5.1 Low Cost Of Resources, Tax Advantages To Attract Player Interest 126
10.5.2 Latin America: Recession Impact 127
Table 90 Latin America: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 127
Table 91 Latin America: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 127
Table 92 Latin America: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 128
10.6 Middle East & Africa 128
10.6.1 Rising Research Funding And Partnerships To Drive Market 128
10.6.2 Middle East & Africa: Recession Impact 129
Table 93 Middle East & Africa: Clinical Trial Imaging Market, By Service & Software, 2021–2028 (Usd Million) 129
Table 94 Middle East & Africa: Clinical Trial Imaging Market, By Modality, 2021–2028 (Usd Million) 129
Table 95 Middle East & Africa: Clinical Trial Imaging Market, By End User, 2021–2028 (Usd Million) 130

11 Competitive Landscape 131
11.1 Overview 131
11.2 Key Player Strategies/Right To Win 131
11.2.1 Right-To-Win Approaches Adopted By Players 131
Table 96 Clinical Trial Imaging Market: Strategies Adopted By Key Players 131
11.3 Revenue Share Analysis Of Top Market Players 133
Figure 29 Revenue Share Analysis Of Key Players (2022) 133
11.4 Market Share Analysis 133
Figure 30 Market Share Analysis Of Key Players (2022) 133
Table 97 Clinical Trial Imaging Market: Degree Of Competition 134
11.5 Company Evaluation Matrix (2022) 135
11.5.1 Stars 135
11.5.2 Emerging Leaders 135
11.5.3 Pervasive Players 135
11.5.4 Participants 135
Figure 31 Clinical Trial Imaging Market: Company Evaluation Matrix, 2022 136
11.6 Company Evaluation Matrix For Startups/Smes (2022) 137
11.6.1 Progressive Companies 137
11.6.2 Starting Blocks 137
11.6.3 Responsive Companies 137
11.6.4 Dynamic Companies 137
Figure 32 Clinical Trial Imaging Market: Company Evaluation Matirx For Startups/Smes, 2022 138
11.7 Competitive Benchmarking 138
Figure 33 Product And Geographic Footprint Analysis Of Key Players 138
Table 98 Company Product Footprint 139
Table 99 Company Geographical Footprint 139
11.8 Competitive Scenario 139
11.8.1 Product Launches & Approvals 139
Table 100 Key Product Launches & Approvals (2020–2023) 139
11.8.2 Deals 140
Table 101 Key Deals (2020–2023) 140

12 Company Profiles 141
(Business Overview, Products/Solutions/Services Offered, Recent Developments, Mnm View (Key Strengths/Right To Win, Strategic Choices Made, Weakness/Competitive Threats)*
12.1 Key Players 141
12.1.1 Icon Plc. 141
Table 102 Icon Plc.: Business Overview 141
Figure 34 Icon Plc.: Company Snapshot (2022) 142
12.1.2 Biotelemetry (Philips) 144
Table 103 Biotelemetry: Business Overview 144
Figure 35 Philips Group: Company Snapshot (2022) 145
12.1.3 Medpace Holdings Inc. 147
Table 104 Medpace Holdings Inc.: Business Overview 147
Figure 36 Medpace Holdings Inc.: Company Snapshot (2022) 147
12.1.4 Biomedical Systems Corporation (Ert Clinical) 149
Table 105 Biomedical Systems Corporation: Business Overview 149
12.1.5 Bioclinica Inc. (Clario) 150
Table 106 Bioclinica Inc.: Business Overview 150
12.1.6 Ixico Plc. 154
Table 107 Ixico Plc.: Business Overview 154
Figure 37 Ixico Plc.: Company Snapshot (2022) 154
12.1.7 Resonance Health Analysis Services (Resonance Health) 157
Table 108 Resonance Health Ltd.: Business Overview 157
Figure 38 Resonance Health Ltd.: Company Snapshot (2022) 157
12.1.8 Radiant Sage Llc 159
Table 109 Radiant Sage Llc: Business Overview 159
12.1.9 Intrinsic Imaging (Wcg Clinical) 160
Table 110 Wcg Clinical: Business Overview 160
12.1.10 Cardiovascular Imaging Technologies 161
Table 111 Cardiovascular Imaging Technologies: Business Overview 161
12.2 Other Players 162
12.2.1 Medical Metrics 162
12.2.2 Prism Clinical Imaging 163
12.2.3 Boston Imaging Core Lab 164
12.2.4 Anagram 4 Clinical Trials 164
12.2.5 Lyscaut Medical Imaging Company 165
12.2.6 Calyx Group 165
12.2.7 Biospective 166
12.2.8 Proscan Imaging 167
12.2.9 Micron, Inc. 167
12.2.10 Imaging Endpoints Li Llc. 168
12.2.11 Perspectum 169
12.2.12 Pharmtrace Klinische Entwicklung Gmbh 169
12.2.13 Worldcare Clinical 170
12.2.14 Median Technologies 170
12.2.15 Invicro. Llc. 171
*Details On Business Overview, Products/Solutions/Services Offered, Recent Developments, Mnm View (Key Strengths/Right To Win, Strategic Choices Made, Weakness/Competitive Threats)* Might Not Be Captured In Case Of Unlisted Companies.

13 Appendix 172
13.1 Discussion Guide 172
13.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 176
13.3 Customization Options 178
13.4 Related Reports 178
13.5 Author Details 179

  • Global Radiation Therapy Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Radiation Therapy Devices market was valued at US$ 5449.1 million in 2023 and is anticipated to reach US$ 7088.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in rec......
  • Global Remanufactured Medical Imaging Device Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Refurbishing of medical device refers to restoring used equipment or systems into a condition of safety and effectiveness comparable to new including actions such as repair, rework, update and replacement of worn parts with original parts. The global Remanufactured Medical Imaging Device market was valued at US$ 2887.7 million in 2023 and is anticipated to reach US$ 4107.3 million by 2030, witnessing a CAGR of 5.1% during The forecast period 2024-2030. GE Healthcare, Siemens ......
  • Global Veterinary Diagnostic Imaging Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Veterinary Diagnostic Imaging market size was valued at US$ 929.6 million in 2023. With growing demand in downstream market, the Veterinary Diagnostic Imaging is forecast to a readjusted size of US$ 1370.9 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Veterinary Diagnostic Imaging market. Veterinary Diagnostic Imaging are expected to show stable gro......
  • Global Advanced Visualization Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Advanced Visualization market: According to our latest research, the global Advanced Visualization market looks promising in the next 5 years. As of 2022, the global Advanced Visualization market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Advan......
  • Global Remanufactured Medical Imaging Device Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Remanufactured Medical Imaging Device market size was valued at US$ 2824.9 million in 2023. With growing demand in downstream market, the Remanufactured Medical Imaging Device is forecast to a readjusted size of US$ 4052.6 million by 2030 with a CAGR of 5.3% during review period. The research report highlights the growth potential of the global Remanufactured Medical Imaging Device market. Remanufactured Medical Imaging Devic......
  • Global Gradient Power Amplifier Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The Gradient Power Amplifier market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gradient Power Amplifier market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report pr......
  • Global Intra-Oral Flat Panel Sensor Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Intra-Oral Flat Panel Sensor market size was valued at US$ 323.2 million in 2023. With growing demand in downstream market, the Intra-Oral Flat Panel Sensor is forecast to a readjusted size of US$ 403.4 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Intra-Oral Flat Panel Sensor market. Intra-Oral Flat Panel Sensor are expected to show stable growth i......
  • Global Medical Linear Accelerator Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Medical Linear Accelerator market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical Linear Accelerator is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Medical Linear Accelerator market. Medical Linear Accelerator are expected to show stable growth in the future market. How......
  • Global Digital Impression Standalone Scanners Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Digital Impression Standalone Scanners market size was valued at US$ 195.7 million in 2023. With growing demand in downstream market, the Digital Impression Standalone Scanners is forecast to a readjusted size of US$ 444.8 million by 2030 with a CAGR of 12.4% during review period. The research report highlights the growth potential of the global Digital Impression Standalone Scanners market. Digital Impression Standalone Scan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs